Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Cholecystitis, Acute D041881 1 associated lipids
Gastric Dilatation D013271 1 associated lipids
Stomach Volvulus D013277 1 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Ward PS et al. Excretion of metabolites of prostacyclin and thromboxane by rats with nephrotoxic nephritis: effects of interleukin-1. 1991 Br. J. Pharmacol. pmid:1933130
Esser R et al. Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2. 2005 Br. J. Pharmacol. pmid:15655513
Carmo LG et al. Platelet desensitization induced by arachidonic acid is not due to cyclo-oxygenase inactivation and involves the endoperoxide receptor. 1985 Br. J. Pharmacol. pmid:2994786
Fitzpatrick TM et al. Tromboxane B2 inhibits the pulmonary inactivation of prostaglandin E2 in the dog. 1980 Br. J. Pharmacol. pmid:7000216
Goel RK et al. Effect of ethanol on eicosanoid synthesis by human gastric and colonic mucosal pieces. 1990 Br. J. Pharmacol. pmid:2328396
Anhut H et al. Prostaglandin D2 is the prevailing prostaglandin in the acute inflammatory exudate of urate arthritis in the chicken. 1979 Br. J. Pharmacol. pmid:570865
Giembycz MA et al. Leukotriene D4 receptors are not negatively coupled to adenylyl cyclase in guinea-pig lung parenchyma. 1993 Br. J. Pharmacol. pmid:8385538
Yin K et al. Blood pressure and vascular reactivity changes in spontaneously hypertensive rats fed fish oil. 1991 Br. J. Pharmacol. pmid:1855129
Renesto P et al. Interference of anti-inflammatory and anti-asthmatic drugs with neutrophil-mediated platelet activation: singularity of azelastine. 1991 Br. J. Pharmacol. pmid:1653073
Zhang BL and Sassard J Eicosanoid-dependence of responses of pre- but not postglomerular vessels to noradrenaline in rat isolated kidneys. 1993 Br. J. Pharmacol. pmid:8220883
De La Cruz JP et al. Antiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leucocytes. 1999 Br. J. Pharmacol. pmid:10602334
Okamura T et al. Neuroeffector actions of thromboxane B2 in dog isolated mesenteric arteries. 1988 Br. J. Pharmacol. pmid:3359109
Ciabattoni G et al. Effects of vasoactive intestinal polypeptide on antigen-induced bronchoconstriction and thromboxane release in guinea-pig lung. 1993 Br. J. Pharmacol. pmid:8495242
Ochi T and Goto T Differential effect of FR122047, a selective cyclo-oxygenase-1 inhibitor, in rat chronic models of arthritis. 2002 Br. J. Pharmacol. pmid:11834626
Zingarelli B et al. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity. 1997 Br. J. Pharmacol. pmid:9031736
Sheu JR et al. Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies. 2004 Br. J. Pharmacol. pmid:15289295
Tateson JE et al. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo. 1988 Br. J. Pharmacol. pmid:2840160
Gao YJ and Lee RM Hydrogen peroxide induces a greater contraction in mesenteric arteries of spontaneously hypertensive rats through thromboxane A(2) production. 2001 Br. J. Pharmacol. pmid:11739239
Feuerstein N et al. Leukotrienes C4 and D4 induce prostaglandin and thromboxane release from rat peritoneal macrophages. 1981 Br. J. Pharmacol. pmid:6894882
Bombardieri S et al. The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs. 1981 Br. J. Pharmacol. pmid:6895043
Henrion D et al. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2. 1997 Br. J. Pharmacol. pmid:9146891
Failli P et al. Effect of some cyclooxygenase inhibitors on the increase in guanosine 3':5'-cyclic monophosphate induced by NO-donors in human whole platelets. 1998 Br. J. Pharmacol. pmid:9579743
Alster P and Wennmalm A Effect of nicotine on the formation of prostacyclin-like activity and thromboxane in rabbit aorta and platelets. 1984 Br. J. Pharmacol. pmid:6367870
Burka JF and Garland LG A possible modulatory role for prostacyclin (PGI2) INIgGa-induced release of slow-reacting substance of anaphylaxis in rats. 1977 Br. J. Pharmacol. pmid:339980
Anderegg K et al. Effects of a pyridine derivative thromboxane synthetase inhibitor and its inactive isomer in endotoxic shock in the rat. 1983 Br. J. Pharmacol. pmid:6687819
Ziyyat A et al. Interactions between nitric oxide and prostanoids in isolated perfused kidneys of the rat. 1996 Br. J. Pharmacol. pmid:8886425
Booth RF et al. Inhibitory effect of a selective thromboxane A2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivo. 1989 Br. J. Pharmacol. pmid:2522336
Frazer CE and Ritter JM Recovery of prostacyclin synthesis by rabbit aortic endothelium and other tissues after inhibition by aspirin. 1987 Br. J. Pharmacol. pmid:3297227
Bult H et al. Modification of endotoxin-induced haemodynamic and haematological changes in the rabbit by methylprednisolone, F(ab')2 fragments and rosmarinic acid. 1985 Br. J. Pharmacol. pmid:3838489
Gray PA et al. Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors. 2002 Br. J. Pharmacol. pmid:12429575
Sheu JR et al. The antiplatelet activity of PMC, a potent alpha-tocopherol analogue, is mediated through inhibition of cyclo-oxygenase. 1999 Br. J. Pharmacol. pmid:10455267
Jiménez R et al. Involvement of thromboxane A2 in the endothelium-dependent contractions induced by myricetin in rat isolated aorta. 1999 Br. J. Pharmacol. pmid:10455307
Boukili MA et al. Pharmacological modulation of the effects of N-formyl-L-methionyl-L-leucyl-L-phenylalanine in guinea-pigs: involvement of the arachidonic acid cascade. 1986 Br. J. Pharmacol. pmid:3096407
Förster W and Pönicke K Influence of sympathomimetic drugs (1-phenyl-2-amino-ethan-1-ol derivatives) on the biosynthesis of prostaglandins and thromboxane B2. 1983 Br. J. Pharmacol. pmid:6403094
Mallarkey G and Smith GM A comparative study of the involvement of the prostaglandin H2/thromboxane A2 pathway in intravascular platelet aggregation in guinea-pigs and rats. 1985 Br. J. Pharmacol. pmid:3156648
Riendeau D et al. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. 1997 Br. J. Pharmacol. pmid:9146894
Lees P et al. Serum thromboxane in the horse and its inhibition by aspirin, phenylbutazone and flunixin. 1987 Sep-Oct Br. Vet. J. pmid:3119142
Delatour P et al. Pharmacodynamics and chiral pharmacokinetics of carprofen in calves. 1996 Br. Vet. J. pmid:8680841
McKellar QA et al. Serum thromboxane generation by platelets in several domestic animal species. 1990 Sep-Oct Br. Vet. J. pmid:2224484
Taylor PM et al. Flunixin in the cat: a pharmacodynamic, pharmacokinetic and toxicological study. 1994 May-Jun Br. Vet. J. pmid:8044665
Lees P and Taylor PM Pharmacodynamics and pharmacokinetics of flunixin in the cat. 1991 Jul-Aug Br. Vet. J. pmid:1913126
Nobutoki T et al. Fluctuating hearing loss, episodic headache, and stroke with platelet hyperaggregability: coexistence of auditory neuropathy and cochlear hearing loss. 2006 Brain Dev. pmid:16168600
Patel PM et al. Differential temperature sensitivity of ischemia-induced glutamate release and eicosanoid production in rats. 1994 Brain Res. pmid:7953685
Cach R et al. Microvascular spasm is mediated by vasopressin fibers in the rat hippocampal slice. 1989 Brain Res. pmid:2706515
Busija DW et al. Acetylcholine dramatically increases prostanoid synthesis in piglet parietal cortex. 1988 Brain Res. pmid:3359178
Petroni A et al. Effects of hypoxia and recovery on brain eicosanoids and carbohydrate metabolites in rat brain cortex. 1987 Brain Res. pmid:3607494
Hynes N et al. Leukotrienes in brain: natural occurrence and induced changes. 1991 Brain Res. pmid:1933275
Cach R et al. Blood-borne factors regulating microvascular constriction in the rat hippocampal slice. 1987 Brain Res. pmid:3620912
Hartung HP et al. Recombinant interleukin-1 beta stimulates eicosanoid production in rat primary culture astrocytes. 1989 Brain Res. pmid:2501001
Faden AI et al. Effects of BW755C, a mixed cyclo-oxygenase-lipoxygenase inhibitor, following traumatic spinal cord injury in rats. 1988 Brain Res. pmid:3143469
Seregi A et al. Decreased levels of brain cyclo-oxygenase products as a possible cause of increased seizure susceptibility in convulsion-prone gerbils. 1984 Brain Res. pmid:6430471
Pettigrew LC et al. Delayed elevation of platelet activating factor in ischemic hippocampus. 1995 Brain Res. pmid:8590061
Constable AL et al. Production of prostanoids by Lewis rat Schwann cells in vitro. 1994 Brain Res. pmid:8173981
Andrus PK et al. Effects of the lipid peroxidation inhibitor tirilazad mesylate (U-74006F) on gerbil brain eicosanoid levels following ischemia and reperfusion. 1994 Brain Res. pmid:7820653
Ahmad M et al. Prolonged opportunity for neuroprotection in experimental stroke with selective blockade of cyclooxygenase-2 activity. 2009 Brain Res. pmid:19446533
Aïd S and Bosetti F Gene expression of cyclooxygenase-1 and Ca(2+)-independent phospholipase A(2) is altered in rat hippocampus during normal aging. 2007 Brain Res. Bull. pmid:17499644
Tuppo EE et al. Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer's disease. 2001 Brain Res. Bull. pmid:11397549
Akarsu ES et al. Effect of ciliary neurotrophic factor on body temperature and cerebrospinal fluid prostanoids in the cat. 1998 Brain Res. Bull. pmid:9434196
Petroni A et al. Eicosanoid and inositol phosphate response to platelet-activating factor (PAF) and to a PAF antagonist in rat astroglial cells. 1994 Brain Res. Dev. Brain Res. pmid:8026072
Petrikova M et al. Carvedilol--a beta-blocker with considerable antiaggregatory effect on human blood platelets. 2005 Bratisl Lek Listy pmid:15869009
Gajdos M et al. [The effect of monotherapy with ciprofibrate and in combination with acetylsalicylic acid on the spectrum of lipids, thromboxane and fibrinogen in patients with atherosclerosis and hyperlipoproteinemia]. 1999 Bratisl Lek Listy pmid:10645034
Kasjanovová D and Baláz V [Functional status of thrombocytes in men of various age groups]. 1990 Bratisl Lek Listy pmid:2224554
Rajec J et al. Biochemical evaluation of the antiplatelet effect of aspirin in patients at different levels of cardiovascular risk. 2008 Bratisl Lek Listy pmid:18814431
Kasjanovová D [Functional status of thrombocytes in men and women in younger age groups]. 1993 Bratisl Lek Listy pmid:8004501
Röth E Effect of Ca-antagonists, beta-blockers and antioxidant during reperfusion period. 1991 Mar-Apr Bratisl Lek Listy pmid:2029661
Lamy M et al. Biochemical pathways of acute lung injury. 1985 May-Jun Bull Eur Physiopathol Respir pmid:3873973
Sakanishi N et al. Thromboxane A2 and hemodynamic-biochemical parameters in canine endotoxin shock. 1983 Bull. Tokyo Med. Dent. Univ. pmid:6580966
Huang YS et al. Roles of thromboxane and its inhibitor anisodamine in burn shock. 1990 Burns pmid:2257065
Yregård L et al. Influence of local anaesthetics on inflammatory activity postburn. 2003 Burns pmid:12781610
Huang YS et al. Serial experimental and clinical studies on the pathogenesis of multiple organ dysfunction syndrome (MODS) in severe burns. 1998 Burns pmid:9915670
Huang YS et al. Effect of smoke inhalation injury on thromboxane levels and platelet counts. 1988 Burns Incl Therm Inj pmid:3250716
Girotti MJ et al. Comparison of regional pulmonary perfusion in lobar pneumonia during high frequency and conventional mechanical ventilation in sheep. 1987 Can J Anaesth pmid:3581395
Licker M et al. Chronic angiotensin converting inhibition does not influence renal hemodynamic and function during cardiac surgery. 1999 Can J Anaesth pmid:10442956
Byrick RJ et al. Corticosteroids do not inhibit acute pulmonary response to fat embolism. 1990 Can J Anaesth pmid:2193732
Byrick RJ et al. Prostanoid production and pulmonary hypertension after fat embolism are not modified by methylprednisolone. 1991 Can J Anaesth pmid:1934222
Landymore RW et al. Correlation between the effects of aspirin and dipyridamole on platelet function and prevention of intimal hyperplasia in autologous vein grafts. 1988 Jan-Feb Can J Cardiol pmid:3359354
Gerrard JM et al. The structured interview elicits a differential prostacyclin response in A and B behaviour types. 1991 Can J Cardiol pmid:2070285
Klein RC et al. Absence of differential inhibition of thromboxane A2 and prostacyclin by low and high dose aspirin in coronary artery disease. 1987 Can J Cardiol pmid:3322532
Shizukuda Y et al. Effect of prednisolone on myocardial infarct healing: characteristics and comparison with indomethacin. 1991 Can J Cardiol pmid:1768984
Chou TZ et al. Effect of felodipine-ER on blood pressure, platelet function, and rheological properties in hypertension. 1993 Can J Cardiol pmid:8394193
Moreno A et al. Prostacyclin-thromboxane balance and retinal vascular pattern in rats with experimentally induced diabetes. 1995 Can. J. Ophthalmol. pmid:7627895
Tosaki A et al. Effect of cicletanine on reperfusion-induced arrhythmias and its relation to 6-keto-PGF1 alpha and thromboxane B2 release. 1991 Can. J. Physiol. Pharmacol. pmid:2059911
Datar S et al. Effect of cyclooxygenase and thromboxane synthetase inhibition on furosemide-stimulated plasma renin activity. 1987 Can. J. Physiol. Pharmacol. pmid:3105853
Rodrigue ME et al. Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats. 2005 Can. J. Physiol. Pharmacol. pmid:16049546
Gerrard JM Measurements of 6-keto-prostaglandin F1 alpha and thromboxane B2 in bleeding time blood: relation to bleeding and vascular disorders? 1989 Can. J. Physiol. Pharmacol. pmid:2688855
Kitamura R et al. Thiopental enhances human platelet aggregation by increasing arachidonic acid release. 2001 Can. J. Physiol. Pharmacol. pmid:11697744
Kaushal RD and Wilson TW Effect of furegrelate on renal plasma flow after angiotensin II infusion. 1990 Can. J. Physiol. Pharmacol. pmid:2328452
Liao CH et al. Antiplatelet effect of demethyldiisoeugenol. 1996 Can. J. Physiol. Pharmacol. pmid:9022830
Jancar S et al. Mechanism of action of platelet-activating factor on guinea-pig lung parenchyma strips. 1988 Can. J. Physiol. Pharmacol. pmid:3146431
Smith EF et al. Influence of thromboxane inhibition on the severity of myocardial ischemia in cats. 1980 Can. J. Physiol. Pharmacol. pmid:7378931
Jiang J et al. Endothelin-1 blockade prevents COX2 induction and TXA2 production in the fructose hypertensive rat. 2007 Mar-Apr Can. J. Physiol. Pharmacol. pmid:17612651
Carvalho C et al. Inhibition of airway hyperreactivity, edema, and lung cell infiltration by compound U-83836E in sensitized guinea pigs. 1998 Jul-Aug Can. J. Physiol. Pharmacol. pmid:10030451
Lewis K et al. Effect of neuropeptide Y on bradykinin-induced release of prostacyclin and thromboxane from guinea pig perfused lung. 1997 Can. J. Physiol. Pharmacol. pmid:9276148
Jenkins DK et al. Effects of albumin on fatty acid, protein, and eicosanoid levels in rat mesenteric arterial bed perfusions. 1988 Can. J. Physiol. Pharmacol. pmid:3167681
Gibb W et al. Cyclooxygenase products formed by primary cultures of cells from human chorion laeve: influence of steroids. 1988 Can. J. Physiol. Pharmacol. pmid:3167693
Riendeau D et al. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. 1997 Can. J. Physiol. Pharmacol. pmid:9365818
Jackman BR et al. Comparison of the effects of ketoprofen and flunixin meglumine on the in vitro response of equine peripheral blood monocytes to bacterial endotoxin. 1994 Can. J. Vet. Res. pmid:8004539
King JN The use of intradermal carrageenan in calves to estimate the dose of oxindanac, a nonsteroidal anti-inflammatory drug. 1993 Can. J. Vet. Res. pmid:8269358
Yamamura S et al. Prostaglandin levels of primary bone tumor tissues correlate with peritumoral edema demonstrated by magnetic resonance imaging. 1997 Cancer pmid:9010098
Klausner JM et al. Interleukin-2-induced lung permeability is mediated by leukotriene B4. 1990 Cancer pmid:2173970